COVID-19 Pandemic’s Effects May Provide ESKD Insights
The COVID-19 supplement of the 2020 US Renal Data System 2020 Annual Data Report provides important insights into dialysis and chronic kidney disease (CKD) during the COVID-19 pandemic.
The COVID-19 supplement of the 2020 US Renal Data System 2020 Annual Data Report provides important insights into dialysis and chronic kidney disease (CKD) during the COVID-19 pandemic.
Study results point to a future when whole exome sequencing will be the method of choice for identifying genetic causes of CKD.
Wow! This is the first wordI think of to describe therecent announcement ofthe early termination of the SystolicBlood Pressure Intervention Trial(SPRINT) sponsored by the NationalInstitutes of Health (NIH). The studybegan in the fall of 2009 and includedmore than 9,300 participants aged50 years and older from about 100medical centers in the United Statesand Puerto Rico. The…
The next generation of doctors could be living in your own home.
Having been in academic medicine as a clinician and researcher for more than 2 decades, I have been able to witness first-hand the significant changes that have occurred in the relationship between academic medical centers and the pharmaceutical industry. It would seem that academia and the pharmaceutical industry are a good match. Academic medical centers identify…
The start of 2012 is a good time to look back on the previous year to see the current state of nephrology. What have been the important findings that occurred in the past year, and what do we have to look forward to in the year ahead?
An international research team have identified a number of families suffering from a mutation in the signal peptide of the renin gene that lead to the development of autosomal dominant CKD.
Autosomal dominant interstitial kidney disease is an under-recognized cause of kidney failure. Characterized by a very strong family history of kidney disease, it is a slowly progressive condition that leads to dialysis when patients are in their 40s or older.